Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engineering hyaluronic acid-based cryogels for CD44-mediated breast tumor reconstruction

Materials Today Bio(2022)10.1016/j.mtbio.2022.100207Source: DataRank Database

Engineering hyaluronic acid-based cryogels for CD44-mediated breast tumor reconstruction is a research paper published in Materials Today Bio (2022). On theSindex it has a DataRank of 0. It has been cited 39 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access39 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.77)OA: goldTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Thibault Colombani ORCID,Loek J. Eggermont ORCID,Sidi A. Bencherif ORCID,Mahboobeh Rezaeeyazdi

Live enrichment

PubMed:35198956 PMC:PMC8844817 OpenAlex:https://openalex.org/W4207076796

National Science Foundation

Grant: DMR 1847843

National Institutes of Health

Grant: 1R01EB027705

NIBIB NIH HHS

Grant: R01 EB027705

National Science Foundation

Grant: 1847843

CAREER: Modulating Local Tumor Hypoxia using Cryogel Scaffolds to Regulate Dendritic Cell Function and Activity

National Institutes of Health

Grant: 5R01EB027705-03

Overcoming vaccine-associated hypoxia with advanced biomaterials to enhance cancer immunotherapy

FWCI

3.77

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.sciencedirect.com/science/article/pii/S2590006422000059/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S2590006422000059/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2590006422000059?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2590006422000059?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.mtbio.2022.100207

Fields of Study

Proteoglycans and glycosaminoglycans researchCancer Cells and MetastasisGlycosylation and Glycoproteins Research0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

CD44MedicineHyaluronic acidBreast cancerRadiation therapyChemotherapyCancerOncologyInternal medicineDrugCancer researchCellPharmacologyBiologyTumor ModelsCryogelsMedicine (General)QH301-705.5R5-920Full Length ArticleBiology (General)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being